Zacks says the pair account for about 65% of Lilly's revenue ahead of its Oct. 29 report, with the Foundayo pill's $98 million second quarter also in focus.
Recap by typeshit. Full story at Yahoo Finance.
A general explainer on how GLP-1 receptor agonists affect blood sugar and appetite, with advice on support while taking them.
A sponsored-style look at compounded tirzepatide and semaglutide through telehealth firm Mochi Health, noting compounded drugs aren't FDA approved for safety or quality.
Among the items: Walmart plans free GLP-1 diabetes drugs for employees in 2027, and Verdiva Bio dropped a phase II oral GLP-1 study citing market changes.
Longevity Technology reports BodySpec's new offering targets GLP-1 users worried about muscle, with body scans said to take about 12 minutes.
News-Medical reports that the diabetes and weight loss medicines may also lower the chance of serious complications in the recovery period after an operation.
In a JAMA Network Open study of 3,615 adults, GLP-1 use was 20.5% among cancer survivors versus 26.5% in those without cancer, even though survivors carried more heart and kidney risk.
Loading…